ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,028, issued on June 24, was assigned to THE SCRIPPS RESEARCH INSTITUTE (La Jolla, Calif.).

"Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof" was invented by Weijun Shen (San Diego), Pengyu Yang (San Diego), Huafei Zou (San Diego) and Peter G. Schultz (Carlsbad, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereo...